<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2021.1112053</article-id><article-id pub-id-type="publisher-id">WJCD-113817</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Contribution of Diagnosis Examinations in Pulmonary Embolism
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Machihude</surname><given-names>Pio</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Doguessaga</surname><given-names>Borgiata Atta</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yaovi</surname><given-names>Mignazonzon Afassinou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soulemane</surname><given-names>Pessinaba</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Hamza</surname><given-names>Doles Sama</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Tchaa</surname><given-names>Tchérou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ablavi</surname><given-names>Ena Todo-Alipui</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wiyaou</surname><given-names>Dieudonnné Kaziga</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abalo</surname><given-names>Mario Bakai</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Soodougoua</surname><given-names>Baragou</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Findibé</surname><given-names>Damorou</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Cardiology Department, Sylvanus Olympio University Hospital, Lomé, Togo</addr-line></aff><aff id="aff2"><addr-line>Cardiology Department, Sokode Hospital, Togo</addr-line></aff><aff id="aff4"><addr-line>Cardiology Department, Campus University Hospital, Lomé, Togo</addr-line></aff><aff id="aff1"><addr-line>Cardiology Department, Kara Unviversity Hospital, Kara, Togo</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>12</month><year>2021</year></pub-date><volume>11</volume><issue>12</issue><fpage>564</fpage><lpage>571</lpage><history><date date-type="received"><day>11,</day>	<month>October</month>	<year>2021</year></date><date date-type="rev-recd"><day>10,</day>	<month>December</month>	<year>2021</year>	</date><date date-type="accepted"><day>13,</day>	<month>December</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: 
  We aimed to determine the specificities of pulmonary embolism (PE) investigations and their statistical link according to PE’s degrees of severity. <b>Patients and Methods: </b>It was a cross-sectional study on patient-
   
  records admitted in Cardiology Department for PE, from June 1<sup>st</sup> 2014 to April 30<sup>th</sup> 2019. We studied electrocardiogram (ECG), Chest X-ray, Echocardiographic, D-dimers, CT pulmonary angiographic (CTPA) data. PE diagnosis was retained at the CTPA. PE was classified according to its severity (low, intermediate, and severe). Patients were arbitrarily categorized in 4 groups (G1
   - 
  G4) according to D-dimer level. <b>Results:</b> We retained 110 patient-
   
  records of patients mean aged 56 &#177; 15 years, with female predominance (Sex-ratio F/M = 1.82). Patients with main pulmonary artery’s (MPA) embolism had D-dimer value &gt; 5000 ng/mL. The more proximal embolism was located, the higher D-dimer level was, but no significant association was found between D-dimer level and PE’s severity. CTPA showed bilateral location of embolism in 52% of cases. Severe PE (SPE) was significantly associated to proximal location (main and segmental branches of PA), and repolarization disorders. S<sub>1</sub>Q<sub>3</sub> aspect was associated to intermediate mortality risk PE. On chest X-
  r
  ay, cardiomegaly and the left middle arch convexity were associated to SPE. PAH was significantly associated to SPE. <b>Conclusion:</b> PE, serious disease has the diagnostic challenge according to its clinical presentations. Several findings of PE investigations should be useful for SPE assessment in our areas, especially since CTPA is not often accessible, even in urban cities.
 
</p></abstract><kwd-group><kwd>Pulmonary Embolism</kwd><kwd> D-Dimer</kwd><kwd> Severity</kwd><kwd> Diagnosis</kwd><kwd> Togo</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Pulmonary embolism (PE) is a sudden partial or total obstruction of the pulmonary artery (PA) or one of its branches by a foreign body, most often a blood clot or thrombus [<xref ref-type="bibr" rid="scirp.113817-ref1">1</xref>]. It is ubiquitous, serious and frequent. In Europe, the prevalence of PE is 17 to 42.6% of hospitalized patients and 8 to 52% of post-mortem examinations [<xref ref-type="bibr" rid="scirp.113817-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref3">3</xref>].</p><p>The prevalence of pulmonary embolism (PE) is increasing in sub-Saharan Africa ranging from 1.4% to 7% [<xref ref-type="bibr" rid="scirp.113817-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref8">8</xref>]. PE, a life-threatening condition, is characterized by variable clinical pictures. Investigations for diagnosis of PE are numerous. Electrocardiogram (ECG), chest X-ray, cardiac Doppler ultrasound and D-dimer testing are orientation exams while lung scintigraphy and chest CT angiography are certainty exams [<xref ref-type="bibr" rid="scirp.113817-ref9">9</xref>]. Lung scintigraphy is very scarce in Africa and CT angiography is not always available in most hospitals outside of the capital cities in sub-Saharan Africa. However, PE is an emergency and the clinical picture can rapidly evolve from minor form to severe form [<xref ref-type="bibr" rid="scirp.113817-ref10">10</xref>]. The physician in this context must, from the clinic and the referral examinations, initiate and adapt the therapeutic protocol early, before confirming the diagnosis if possible by thoracic CT angiography. The aims of our study were to determine the particularities of these orientation exams and correlate them with the different degrees of severity of PE.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This was a cross-sectional study on files of patients hospitalized for PE in the cardiology department of the Sylvanus Olympio University Hospital in Lom&#233; from 1<sup>st</sup> June 2014 to 30 April 2019 (5 years).</p><p>Were included in the study, files of patients in whom the diagnosis of PE was confirmed by CT angiography and including data from ECG, chest X-ray, cardiac doppler ultrasound and D-dimers. Incomplete charts and patients who did not perform CT angiography were excluded from this study.</p><p>We reported the interpretations made by cardiologists and radiologists of these examinations. We studied:</p><p>&#183; On the ECG: repolarization disorders such as anterior sub-epicardial ischemia (V1 to V5).</p><p>&#183; On echocardiography: dilation of the right ventricle (RV) defined by RV/LV ratio &gt; 1, dilation of the right atrium (OD) if the area was greater than 18 cm<sup>2</sup>. The RV dysfunction threshold was set at a TAPSE value of less than 16 mm, pulmonary arterial hypertension (PAH) was defined as systolic pulmonary arterial pressure (PAPS) greater than 35 mmHg.</p><p>The diagnosis of PE was confirmed by CT angiography.</p><p>Patient charts were classified according to the severity of PE (low, intermediate or severe risk). The patients were classified into classes according to D-dimers level: group 1 (G1), D-dimers &lt; 1000 ng/mL, group 2 (G2) D-dimers 1001 - 3000 ng/mL, group 3 (G3), D-dimers 3001 - 5000 ng/mL, and group 4 (G4), D-dimers were &gt;5000 ng/mL.</p><p>We did a binary logistic regression. Considering separately each level of D dimers with the severity of PE. We also analyzed each level of severity of PE with thrombus location, electrocardiographic abnormalities, radiographic abnormalities, and echocardiographic data. The threshold of statistical significance was p &lt; 0.05.</p></sec><sec id="s3"><title>3. Results</title><p>Epidemiological characteristics</p><p>One hundred ten cases were included. The mean age of the patients was 56 &#177; 15 years. Sex ratio women/men was 1.82. Women were more affected by PE with a high risk of mortality (60.5% of severe PE versus 39.5% for men). PE was severe in 34.6% of cases and at intermediate risk of death in 42.7% of patients.</p><p>Levels of D-dimer levels depending on the location of the thrombus and the severity of the pulmonary embolism</p><p>In 34% of patients the D-dimer level was between 1000 and 3000 ng/mL and in 14% of the patients the D-dimer level was less than 1000 ng/mL. All patients with a thrombus in the pulmonary artery trunk had a D-dimer level greater than 5000 ng/mL. We found 21% of segmental EPs which also had a D-dimer level greater than 5000 ng/mL (<xref ref-type="fig" rid="fig1">Figure 1</xref>). In patients who had a D-dimer level between 3001 ng/mL and 5000 ng/mL, thrombi were found more in the main branches of PA (29%) and in those who had a lower D-dimer level at 1000 ng/mL and between 1000 ng/mL and 3000 ng/mL, the thrombus was found more in the segmental branches of the PA in 26% and 36% of cases, respectively. Therefore, the more proximal the localization, the higher the level of D-dimers. But there was no significant association between the level of elevation of D-dimers and the severity of PE (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Location of the thrombus and severity of pulmonary embolism</p><p>PE was bilateral in 52% of cases. The branches of the pulmonary artery most</p><p>affected were the segmental branches in 51% of cases followed by the main branches in 46% of cases. The trunk was affected in 5.4% of cases. Severe PE was significantly associated with localization of the thrombus in the trunk or lobar branches (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>ECG abnormalities and severity of pulmonary embolism</p><p>The ECG was normal in 11 patients (10%). Sinus tachycardia was found in 72.7% of cases. An S1Q3 aspect was found in 55%. Among the electrocardiographic abnormalities, anterior repolarization disorder was significantly associated with severe PE and the S1Q3 aspect was significantly present in PE at intermediate risk of mortality (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Chest radiographic aspects</p><p>The chest x-ray was normal in 7% of cases. Convexity of the left middle arch was the most common sign in 93% of cases, followed by cardiomegaly in 79% of cases. Cardiomegaly and convexity of the left middle arch were significantly found in severe PE (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Echocardiographic abnormalities and severity of pulmonary embolism</p><p>Echocardiography was normal in 31.8% of cases. The abnormalies found were mainly right ventricle dilatation (60.9%), right atrium dilatation (59%), pulmonary arterial hypertension (64.5%), paradoxical septum (48.1%), right ventricular</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Association between pulmonary embolism severity and D-dimer level</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="3"  >G1 (n = 15) D-d &lt; 1000 ng/mL</th><th align="center" valign="middle"  colspan="3"  >G2 (n = 37) D-d [1000 - 3000 ng/mL]</th><th align="center" valign="middle"  colspan="3"  >G3 (n = 26) D-d [3001 - 5000 ng/mL]</th><th align="center" valign="middle"  colspan="3"  >G4 (n = 32) D-d &gt; 5000 ng/mL</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >IC 95%</td><td align="center" valign="middle" >p</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >IC 95%</td><td align="center" valign="middle" >p</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >IC 95%</td><td align="center" valign="middle" >p</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >IC 95%</td><td align="center" valign="middle" >p</td></tr><tr><td align="center" valign="middle" >PE with high risk</td><td align="center" valign="middle" >3.3</td><td align="center" valign="middle" >0.8 - 12.5</td><td align="center" valign="middle" >0.08</td><td align="center" valign="middle" >0.3</td><td align="center" valign="middle" >0.1 - 1.2</td><td align="center" valign="middle" >0.09</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.1 - 2.1</td><td align="center" valign="middle" >0.37</td><td align="center" valign="middle" >2.1</td><td align="center" valign="middle" >0.7 - 6.7</td><td align="center" valign="middle" >0.18</td></tr><tr><td align="center" valign="middle" >PE with intermediate risk</td><td align="center" valign="middle" >0.3</td><td align="center" valign="middle" >0.1 - 1.4</td><td align="center" valign="middle" >0.58</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" >0.3 - 1.9</td><td align="center" valign="middle" >0.67</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >0.6 - 3.7</td><td align="center" valign="middle" >0.41</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >0.6 - 3.5</td><td align="center" valign="middle" >0.41</td></tr><tr><td align="center" valign="middle" >PE with low risk</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >0.4 - 4.9</td><td align="center" valign="middle" >0.13</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" >0.4 - 1.9</td><td align="center" valign="middle" >0.66</td><td align="center" valign="middle" >0.6</td><td align="center" valign="middle" >0.2 - 1.5</td><td align="center" valign="middle" >0.27</td><td align="center" valign="middle" >1.6</td><td align="center" valign="middle" >0.7 - 4.0</td><td align="center" valign="middle" >0.26</td></tr></tbody></table></table-wrap><p>G1: Group 1; G2: Group 2; G3: Group 3; G4: Group 4; D-d: D-dimer; PE: pulmonary embolism.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Association of paraclinical signs and severity of pulmonary embolism</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle"  colspan="3"  >EP s&#233;v&#232;re (n = 24)</th><th align="center" valign="middle"  colspan="3"  >EP interm&#233;diaire (n = 34)</th><th align="center" valign="middle"  colspan="3"  >EP faible (n = 52)</th></tr></thead><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >IC 95%</td><td align="center" valign="middle" >p</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >IC 95%</td><td align="center" valign="middle" >p</td><td align="center" valign="middle" >OR</td><td align="center" valign="middle" >IC 95%</td><td align="center" valign="middle" >p</td></tr><tr><td align="center" valign="middle" >Thrombus location</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Trunk</td><td align="center" valign="middle" >20.3</td><td align="center" valign="middle" >2.6 - 157.9</td><td align="center" valign="middle" >0.004</td><td align="center" valign="middle" >0.4</td><td align="center" valign="middle" >0.1 - 2.9</td><td align="center" valign="middle" >0.96</td><td align="center" valign="middle" >0.4</td><td align="center" valign="middle" >0.1 - 2.4</td><td align="center" valign="middle" >0.28</td></tr><tr><td align="center" valign="middle" >Main branches</td><td align="center" valign="middle" >2.1</td><td align="center" valign="middle" >0.7 - 5.9</td><td align="center" valign="middle" >0.18</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >0.5 - 3.9</td><td align="center" valign="middle" >0.40</td><td align="center" valign="middle" >0.4</td><td align="center" valign="middle" >0.1 - 1.1</td><td align="center" valign="middle" >0.06</td></tr><tr><td align="center" valign="middle" >Lobary branches</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >1.0 - 8.5</td><td align="center" valign="middle" >0.04</td><td align="center" valign="middle" >0.3</td><td align="center" valign="middle" >0.1 - 0.9</td><td align="center" valign="middle" >0.04</td><td align="center" valign="middle" >1.1</td><td align="center" valign="middle" >0.4 - 2.7</td><td align="center" valign="middle" >0.80</td></tr><tr><td align="center" valign="middle" >Segmental branches</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >0.5 - 4.3</td><td align="center" valign="middle" >0.45</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >0.3 - 2.6</td><td align="center" valign="middle" >0.99</td><td align="center" valign="middle" >0.8</td><td align="center" valign="middle" >0.3 - 1.8</td><td align="center" valign="middle" >0.52</td></tr><tr><td align="center" valign="middle" >Electrocardiographic abnormalities</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Repolarization abnormalities</td><td align="center" valign="middle" >3.4</td><td align="center" valign="middle" >1.1 - 10.4</td><td align="center" valign="middle" >0.03</td><td align="center" valign="middle" >1.5</td><td align="center" valign="middle" >0.5 - 4.1</td><td align="center" valign="middle" >0.41</td><td align="center" valign="middle" >0.4</td><td align="center" valign="middle" >0.1 - 0.9</td><td align="center" valign="middle" >0.04</td></tr><tr><td align="center" valign="middle" >Right QRS axis</td><td align="center" valign="middle" >1.7</td><td align="center" valign="middle" >0.2 - 12.3</td><td align="center" valign="middle" >0.61</td><td align="center" valign="middle" >1.4</td><td align="center" valign="middle" >0.2 - 7.6</td><td align="center" valign="middle" >0.72</td><td align="center" valign="middle" >0.5</td><td align="center" valign="middle" >0.1 - 3.1</td><td align="center" valign="middle" >0.45</td></tr></tbody></table></table-wrap><p>dysfunction with TAPSE ≤ 15 mm (46.3%). Pulmonary arterial hypertension (PAH) was the only abnormality significantly associated with severe PE (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>This study focused on the peculiarities of D-dimers, ECG, chest X-ray and echocardiography in PE at Sylvanus Olympio University hospital in Lom&#233;.</p><p>Female predominance was founded in our study. This female predominance was also observed in the severity of PE. We believe that the mechanical and especially hormonal characteristics of the specific etiological factors of PE in women are the main reasons. Indeed, among the causes of venous thromboembolic disease (VTD), female sex has particularities: sedentary lifestyle and obesity which most affect women in our society [<xref ref-type="bibr" rid="scirp.113817-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref12">12</xref>], the exclusive part of pregnancy, peripartum, peripartum cardiomyopathy, use of estrogen-progestogens, exclusivity of cervical, ovarian, uterine, uterine myomas and ovarian cysts in women [<xref ref-type="bibr" rid="scirp.113817-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref13">13</xref>].</p><p>Average age of the patients was 56.74 &#177; 15.53 years. In general, all authors agree on a significant increase in the incidence of VTD after 40 years [<xref ref-type="bibr" rid="scirp.113817-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref16">16</xref>].</p><p>In our series, the branches of the PA most affected were segmental branches in 51% of the cases, followed by main branches in 46%. Ngamami et al. in Congo also had founded a predominance of segmental branches in 62.5% of cases [<xref ref-type="bibr" rid="scirp.113817-ref17">17</xref>]. We found 5.4% of patients with truncal PE like Houenassi et al. in Benin, who had founded 5% [<xref ref-type="bibr" rid="scirp.113817-ref14">14</xref>]. This is likely an underestimation as the patient with truncal PE is at risk to not reach hospital, or to die in hospital before diagnostic confirmation. Autopsies are exceptional in our hospitals in sub-Saharan Africa.</p><p>We have arbitrarily distributed the D-dimers between certain random values in order to better understand a link between the level of D-dimers and the severity of PE. Ghanima [<xref ref-type="bibr" rid="scirp.113817-ref18">18</xref>] found a significant association between the level of D-dimer and the most proximal level of PE as in our study. Contrary to our results, he also found a significant association between the level of elevation of D-dimers and the severity of PE with potential interest as a prognostic indicator of severity of PE [<xref ref-type="bibr" rid="scirp.113817-ref18">18</xref>].</p><p>There was no association between D-dimer level and severity of PE in our study. D-dimers were therefore not an element that could allow us to assess the severity of PE in our context. But we observed that the truncal PE had D-dimers greater than 5000 ng/mL. So D-dimers greater than 5000 ng/mL predict a proximal location of a thrombus and therefore potentially a progressive PE with severity.</p><p>Anterior repolarization anomalies were significantly more found in severe PE. The electrocardiographic signs found are those already reported in the literature with similar proportions [<xref ref-type="bibr" rid="scirp.113817-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref19">19</xref>].</p><p>A chest X-ray is not a key diagnostic exam for PE, and its normality does not preclude a diagnosis of PE [<xref ref-type="bibr" rid="scirp.113817-ref20">20</xref>]. Especially since the evolution of PE towards gravity is unpredictable. Cardiomegaly and convexity of the left middle arch were the radiographic signs associated with severe PE. They are the radiologic translation of dilation of the right heart chambers and pulmonary arterial hypertension, often signs of severity [<xref ref-type="bibr" rid="scirp.113817-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.113817-ref21">21</xref>].</p><p>S1Q3 aspect was significantly associated with intermediate risk PE. Anterior abnormalities on ECG, radiological cardiomegaly and convexity of the left middle arch could constitute paraclinical signs of the severity of PE in our settings where CT angiography is rarely available, and where patients are often not insured, with very limited of finances. Before patients confirm the diagnosis of PE, these clinical signs could participate in the classification of the severity of PE in our context.</p><p>Echocardiography is an exam that classifies PE according to severity. It is indeed easy to perform and non-invasive. She usually shows indirect signs of PE and indicating hemodynamic impact. Lambert in France found right ventricular dilation in 48.7% of cases, pulmonary arterial hypertension (PAH) in 45.2% of cases and intracardiac thrombus in 2.2% of cases [<xref ref-type="bibr" rid="scirp.113817-ref9">9</xref>]. In Togo, Pio in 2014 found PAH in 50% and thrombus in 3.44% [<xref ref-type="bibr" rid="scirp.113817-ref21">21</xref>]. There are indeed small variations depending on the studies in these results but in each series the order of the lesions was the same: right cavitary dilation first followed by PAH, paradoxical septum and right ventricular dysfunction. Finally, a normal echocardiogram is more in favor of a PE with a low risk of mortality.</p><p>In total, D-dimer level greater than 5000 ng/mL is suspect of a truncal PE and therefore potentially progressing to severity. The presence of anterior repolarization disorder on ECG, cardiomegaly, convexity of the left middle arch on chest X-ray, presence of PAH on echocardiography is significantly associated with severe PE. The S1Q3 aspect is significantly associated with PE with intermediate risk of mortality. These signs should help clinicians to anticipate the management and monitoring of these patients even if they appear to have a less worrisome clinical picture of PE.</p></sec><sec id="s5"><title>5. Conclusion</title><p>PE is a serious condition and its positive diagnosis is sometimes difficult due to the clinical polymorphism. There was no association between D-dimer level and severity of PE, but rather with the location of the thrombus. Severe PE was more truncal. S1Q3 aspect is significantly associated with PE with intermediate risk of mortality. ECG repolarization abnormalities, cardiomegaly and convexity of the left middle arch on the chest x-ray were associated with severe PE. PAH was the sign most significantly associated with severe PE on echocardiography. These signs could be elements of assessing the severity of PE in our low income countries.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Pio, M., Atta, D.B., Afassinou, Y.M., Pessinaba, S., Sama, H.D., Tch&#233;rou, T., Todo-Alipui, A.E., Kaziga, W.D., Bakai, A.M., Baragou, S. and Damorou, F. (2021) Contribution of Diagnosis Examinations in Pulmonary Embolism. World Journal of Cardiovascular Diseases, 11, 564-571. https://doi.org/10.4236/wjcd.2021.1112053</p></sec></body><back><ref-list><title>References</title><ref id="scirp.113817-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Cohen, A. (1997) Embolie Pulmonaire. In: Cardiologie et pathologies cardiovasculaires, Estem, Paris, 775-816.</mixed-citation></ref><ref id="scirp.113817-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Boukinda, F., Planchon, B. and Okondza, J. (1996) La thrombophlébite profonde des membres inférieurs: Une curiosité clinique en Afrique noire; Notre expérience à Brazzaville. Médecine d’Afrique Noire, 43, 63-65.</mixed-citation></ref><ref id="scirp.113817-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Barrelier, M.T., Lezin, B., Landy, S. and Le Hello, C. (2001) Prévalence de la hrombose veineuse diagnostiquée par échographie-doppler des membres inférieurs dans la suspicion d’embolie pulmonaire et dans l’embolie pulmonaire confirmée. Journal des Maladies Vasculaires, 26, 23-30.</mixed-citation></ref><ref id="scirp.113817-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Pio, M., Baragou, S., Afassinou, Y., Pessinaba, S., Atta, B., Ehlan, K., Goeh-akue, E. and Damorou, F. (2013) Actualité sur la maladie thromboembolique veineuse au CHU Sylvanus Olympio de Lome. Journal de la Recherche Scientifique de l’Université de Lomé, 15, 93-100.</mixed-citation></ref><ref id="scirp.113817-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Diall, I.B., Coulibaly, S., Minta, I., Ba, Ho., Diakite, M., Sidibe, N., et al. (2011) Etiologie, clinique et évolution de l’embolie pulmonaire à propos de 30 cas. Mali Médical, 26, 1-6.</mixed-citation></ref><ref id="scirp.113817-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Niakara, A., Drabo, Y.J. and Cambered, Y. (2002) Cardiovascular Diseases and HIV Infection: Study of 79 Cases at the National Hospital of Ouagadougou (Burkina Faso). Bulletin de la Société de Pathologie Exotique, 95, 23-26.</mixed-citation></ref><ref id="scirp.113817-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Maniboliot, M.S., Kanikomo, D., Ndiaye, M. and Sow, ML. (2013) La mort subite de l’adulte, particularités en Afrique, à propos de 476 cas. Pan African Medical Journal, 16, Article No. 125. https://doi.org/10.11604/pamj.2013.16.125.2490</mixed-citation></ref><ref id="scirp.113817-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Olié, V., Chin, F., Lamarche-Vadel, A. and De Peretti, C. (2010) La maladie veineuse thromboembolique: Patients hospitalisés et mortalité en France en 2010. Bulletin Epidémiologique Hebdomadaire, No. 33-34, 417-424.</mixed-citation></ref><ref id="scirp.113817-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Lambert, B. (2003) L’embolie pulmonaire en pratique clinique: à propos de 839 cas consécutifs en hopital général: étude STEP. Sciences du Vivant.  
https://hal.univ-lorraine.fr/hal-01734190</mixed-citation></ref><ref id="scirp.113817-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Bahloul, M., Chaari, A., Dammak, H., Abid, L., Salima, D., Ksibi, H., Samet, M., Kallel, H. and Bouaziz, M. (2014) L’embolie pulmonaire fibrino-cruorique: Fréquence, physiopathologie, tableau clinique et traitement. La tunisie médicale, 92, 435-447.</mixed-citation></ref><ref id="scirp.113817-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Baragou, S., Pio, M., Afassinou, Y.M., Hountondji, A.F. and Dovi-Akue, G. (2013) Cardiovascular Risk Factors in Black African Obese Patients: A Multicentric Comparative Study in 1512 Patients in Lome (Togo). Obesity Weight Loss Therapy, 3, Article No. 184. https://doi.org/10.4172/2165-7904.1000184</mixed-citation></ref><ref id="scirp.113817-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Van Hylckama Vlieg, A., Helmerhorst, F.M., Vandenbroucke, J.P., Doggen, C.J. and Rosendaal, F.R. (2009) The Venous Thrombotic Risk of Oral Contraceptives, Effects of Oestrogen Dose and Progestogen Type: Results of the Mega Case-Control Study. BMJ, 339, Article No. b2921. https://doi.org/10.1136/bmj.b2921</mixed-citation></ref><ref id="scirp.113817-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">N’djessan, J.J., Soya, E., Monney, E., Kouame, J., Takogue, R. and Konin, C. (2018) Evaluation de la mortalité précoce de l’embolie pulmonaire à l’Unité des Soins Intensifs de l’Institut de Cardiologie d’Abidjan. Cardiologie tropicale, No. 152, 44-55.</mixed-citation></ref><ref id="scirp.113817-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Adoh, A., Kouame, A.N., Kouassi, Y.F., N’Dory, R. and Assambdi, M.O. (1992) Thromboses veineuses profondes des membres chez le sujet noir Africain. Médecine Tropicale, 52, 131-137.</mixed-citation></ref><ref id="scirp.113817-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Pottier, P., Planchon, B., Pistorius, M.A. and Grolleau, J.Y. (2001) Facteurs de risque et incidence de la maladie thromboembolique veineuse en médecine interne: Une étude descriptive prospective sur 947 patients hospitalisés. Revue de Médecine Interne, 22, 348-359. https://doi.org/10.1016/S0248-8663(01)00347-2</mixed-citation></ref><ref id="scirp.113817-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Mahe, I., Caulin, C. and Bergmann, J.F. (2005) L’age, un facteur indépendant de risque de thrombose: Données épidémiologiques. La Presse Médicale, 34, 878-886.  
https://doi.org/10.1016/S0755-4982(05)84068-0</mixed-citation></ref><ref id="scirp.113817-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Mongo Ngamami, S.F., Ellenga Mbolla, B.F., Kouala Landa, C.M., Makani Bassakouahou, J.K., Ikama, M.S., Bakekolo, R.P., et al. (2018) Aspects échocardiographies et scanographiques au cours de l’embolie pulmonaire aigue dans le service de cardiologie du chu de Brazzaville (Congo). Annales de l’université Marien N’gouabi, 18, 51-57.</mixed-citation></ref><ref id="scirp.113817-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Ghanima, W., Abdelnoor, M., Holmen, L.O., Nielssen, B.E., Ross, S. and Sandset, P.M. (2007) D-Dimer Level Is Associated with the Extent of Pulmonary Embolism. Thrombosis Research, 120, 281-288. https://doi.org/10.1016/j.thromres.2006.08.006</mixed-citation></ref><ref id="scirp.113817-ref19"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Houenassi. M.</surname><given-names> Sacca-Vehounkpe</given-names></name>,<name name-style="western"><surname> J.</surname><given-names> Tchabi</given-names></name>,<name name-style="western"><surname> Y.</surname><given-names> Dossou-Yovo</given-names></name>,<name name-style="western"><surname> R.</surname><given-names> Saizonou</given-names></name>,<name name-style="western"><surname> F.</surname><given-names> Biaou</given-names></name>,<name name-style="western"><surname> O.</surname><given-names> D’Almeida</given-names></name>,<name name-style="western"><surname> M.M. and Agboton</surname><given-names> H. </given-names></name>,<etal>et al</etal>. (<year>2013</year>)<article-title>Evaluation de la prise en charge de l’embolie pulmonaire dans un pays à faible niveau socio-économique: Cas du Bénin</article-title><source> Cardiologie Tropicale</source><volume> 136</volume>,<fpage> 1</fpage>-<lpage>5</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.113817-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Robert-Ebadi, H. and Righini, M. (2011) Diagnostic de l’embolie pulmonaire. Revue des Maladies Respiratoires, 28, 790-799. https://doi.org/10.1016/j.rmr.2010.10.039</mixed-citation></ref><ref id="scirp.113817-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Pio, M., Goeh-akue, E., Baragou, S., Afassinou, Y., Sama, D.H., Mossi, K.E., Atta, B., Dandonougbo, K., Ehlan, E. and Damorou, F. (2014) Embolies pulmonaires: Signes cliniques et facteurs étiologiques au CHU Sylvanus Olympio de Lomé. Angéiologie, 66, 53-59.</mixed-citation></ref></ref-list></back></article>